Cetyl Myristoleate | Health Notes at WWSM | Health Information at WWSM

Cetyl Myristoleate

Also indexed as: Cis-9-Cetyl Myristoleate, CMO

Cetyl myristoleate (CMO) is the common name for cis-9-cetyl myristoleate. CMO was discovered in 1972 by Harry W. Diehl, Ph.D., a researcher at the National Institutes of Health. At the time, Dr. Diehl was responsible for testing anti-inflammatory drugs on lab animals. In order for him to test the drugs, he first had to artificially induce arthritis in the animals by injecting a heat-killed bacterium called Freund’s adjuvant. Dr. Diehl discovered that Swiss albino mice did not get arthritis after injection of Freund’s adjuvant. Eventually, he was able to determine that cetyl myristoleate was the factor present naturally in mice that was responsible for this protection. When CMO was injected into various strains of rats, it offered the same protection against arthritis.¹

Where is it found?

Cetyl myristoleate is found in certain animals, including cows, whales, beavers, and mice. As a nutritional supplement it is found in a highly purified, refined form in capsules and tablets. CMO is also available in creams and lotions for topical application.

CMO has been used in connection with the following conditions (refer to the individual health concern for complete information):

Science Ratings	Health Concerns
	Osteoarthritis Rheumatoid arthritis
Reliable and relatively consistent scientific data showing a substantial health benefit. Contradictory, insufficient, or preliminary studies suggesting a health benefit or minimal health benefit. For a herb, supported by traditional use but minimal or no scientific evidence. For a supplement, little scientific support and/or minimal health benefit.

Science Ratings

Health Concerns

Osteoarthritis

Rheumatoid arthritis

Reliable and relatively consistent scientific data showing a substantial health benefit.
2Stars

Contradictory, insufficient, or preliminary studies suggesting a health benefit or minimal health benefit.
1Star

For a herb, supported by traditional use but minimal or no scientific evidence. For a supplement, little scientific support and/or minimal health benefit.

Who is likely to be deficient?

As CMO is not an essential nutrient, no deficiency state exists.

How much is usually taken?

Generally, CMO is taken in the amount of 400 to 500 mg daily for 30 days.

Are there any side effects or interactions?

No side effects or drug interactions have been reported.

At the time of writing, there were no well-known drug interactions with cetyl myristoleate.

References
(To view, roll mouse over the "References" heading; to hide, click on the heading)

Learn more about Healthnotes, the company.

Learn more about the authors of Healthnotes.

The information presented in Healthnotes is for informational purposes only. It is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over the counter medication is also available. Consult your doctor, practitioner, and/or chemist for any health problem and before using any supplements or before making any changes in prescribed medications. Information expires September 2008.

Skip to:

Skip to:

Where is it found?

Who is likely to be deficient?

How much is usually taken?

Are there any side effects or interactions?